BIOMAT Database Logo BIOMAT Database Logo

Bleomycin-resistant DNA synthesis in ataxia telangiectasia cells. 1981

P Cramer, and R B Painter

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008769 Methylnitronitrosoguanidine A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. Methylnitrosonitroguanidine,Nitrosomethylnitroguanidine,Nitrosonitromethylguanidine,MNNG,N-Methyl-N'-nitro-N-nitrosoguanidine,N Methyl N' nitro N nitrosoguanidine
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001260 Ataxia Telangiectasia An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23). Louis-Bar Syndrome,Ataxia Telangiectasia Syndrome,Ataxia-Telangiectasia,Telangiectasia, Cerebello-Oculocutaneous,Louis Bar Syndrome,Syndrome, Ataxia Telangiectasia,Syndrome, Louis-Bar

Related Publications

P Cramer, and R B Painter
Analysis of bleomycin-resistant DNA synthesis in cells from an inherited human disorder, ataxia telangiectasia.
January 1990, Basic life sciences,
P Cramer, and R B Painter
The effect of bleomycin on DNA synthesis in ataxia telangiectasia lymphoid cells.
January 1982, Environmental mutagenesis,
P Cramer, and R B Painter
Bleomycin induced inhibition of DNA synthesis in ataxia-telangiectasia cell lines.
September 1981, Biochemical and biophysical research communications,
P Cramer, and R B Painter
DNA replication and repair in ataxia telangiectasia cells exposed to bleomycin.
April 1983, Mutation research,
P Cramer, and R B Painter
The response of ataxia telangiectasia cells to bleomycin.
January 1979, Nucleic acids research,
P Cramer, and R B Painter
Unusual sensitivity of ataxia telangiectasia cells to bleomycin.
March 1979, Cancer research,
P Cramer, and R B Painter
Unscheduled DNA synthesis in cultured ataxia telangiectasia fibroblast-like cells.
September 1980, Mutation research,
P Cramer, and R B Painter
Altered DNA synthesis in irradiated and unirradiated ataxia-telangiectasia cells.
January 1985, Kroc Foundation series,
P Cramer, and R B Painter
Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells.
August 1980, Nucleic acids research,
P Cramer, and R B Painter
Ataxia-telangiectasia cell extracts confer radioresistant DNA synthesis on control cells.
April 1986, Experimental cell research,
Copied contents to your clipboard!